Clinical Trial

Immune Responses to Dengue and Sepsis

Study acronym: DEN-SEP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this research study is to help the investigators better understand serious dengue disease. The investigators will collect clinical information and up to four blood samples from participants with dengue, sepsis, or healthy people. The investigators will perform multiple analyses on the blood samples and compare results between dengue patients and those with sepsis and healthy people.
Trial Details
NCT Number NCT07040202
Lead Sponsor Institut Pasteur du Cambodge
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Dengue, Sepsis
Enrollment 240 participants
Start Date 2025-06-02
Primary Completion 2025-11 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-27